GILEAD SCIENCES, INC. - Common Stock (GILD)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,033,439,494
Share change
+14,098,515
Total reported value
$70,880,576,523
Put/Call ratio
76%
Price per share
$68.61
Number of holders
1,650
Value change
+$951,368,462
Number of buys
738
Number of sells
821

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2024

As of 30 Jun 2024, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,650 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,033,439,494 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Capital Research Global Investors, STATE STREET CORP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, and FMR LLC. This page lists 1,666 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.